Authors: Mireya Fernández-Fournier, MD, Javier Díaz de Terán, MD, Antonio Tallón Barranco, MD, PhD and Inmaculada Puertas, MD, PhD In 2006, an adjuvant vaccine against 4 human papillomavirus (HPV) types was licensed. By 2012, 45 countries had introduced HPV vaccination.1 HPV encompasses a group of more than 100 viruses, of which at least 13 are high-risk types, responsible for […]